Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

14
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
14
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

11
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
11
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

14
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
14
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

37
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
37
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

213
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
213
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

28
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding Oligonucleotide Stereochemistry: Individual Phosphorothioate Configuration Ratios and Intact Sequence Diastereomeric Composition.

Analytical chemistry·2026
Same author

Unleashing the power of zero-valent platinum single atoms for enhancing low-temperature oxygen activation.

Nature communications·2026
Same author

Interfacial Stabilization of Cu(I) in Ultralow-Dose Cu<sub>2</sub>O/ZIF-8 Heterojunctions Enabling Rapid and Energy-Efficient Genomic Disruption of Pathogens.

Environmental science & technology·2025
Same author

Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder Inhalers.

AAPS PharmSciTech·2025
Same author

Advancing pharmaceutical tablet analysis with laser direct infrared (LDIR) imaging.

Journal of pharmaceutical and biomedical analysis·2025
Same author

Microfiber-Based Triboelectric Acoustic Sensors Enable Self-Powered Ultrasonic Localization and Tracking Underwater.

ACS sensors·2025

Related Experiment Video

Updated: Oct 14, 2025

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

1.8K

An In Vitro Dissolution Method for Testing Extended-Release Tablets Under Mechanical Compression and Sample Friction.

Zongming Gao1, Leo N Y Cao1, Xiaofei Liu1

  • 1US Food and Drug Administration, Center for Drug Evaluation and Research, Division of Complex Drug Analysis, St. Louis, MO, 63110.

Journal of Pharmaceutical Sciences
|November 7, 2021
PubMed
Summary
This summary is machine-generated.

A new Mechanical Apparatus under GI Conditions (MAGIC) better simulates the gastrointestinal (GI) tract for drug dissolution testing. This advanced method revealed a nifedipine extended-release (ER) formulation failed under simulated GI mechanical stress.

Keywords:
Critical quality attributes (CQAs)Extended-release (ER)Gastrointestinal (GI) conditionIn vitro dissolution testingMechanical apparatus under GI condition (MAGIC) systemMedium flow-through configurationSimulated GI compression and friction

More Related Videos

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

18.3K
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.2K

Related Experiment Videos

Last Updated: Oct 14, 2025

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

1.8K
Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

18.3K
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.2K

Area of Science:

  • Pharmaceutical Sciences
  • Biomedical Engineering
  • Drug Delivery Systems

Background:

  • Drug release from oral formulations is vital for absorption.
  • Traditional dissolution tests do not accurately mimic the gastrointestinal (GI) tract's mechanical forces.
  • This limits the prediction of in vivo drug performance for extended-release (ER) dosage forms.

Purpose of the Study:

  • To develop an in vitro dissolution method that better simulates the mechanical conditions of the GI tract.
  • To evaluate the performance of an ER nifedipine formulation under simulated GI conditions.

Main Methods:

  • A novel Mechanical Apparatus under GI Conditions (MAGIC) was designed and built using 3D printing.
  • The MAGIC system features a flow-through dissolution platform with mechanical compression and rotation capabilities.
  • An extended-release nifedipine product was tested under simulated GI conditions, varying medium flow rate and mechanical stress.

Main Results:

  • The polymer matrix-based nifedipine ER formulation failed its controlled release function under simulated GI mechanical compression and friction.
  • The MAGIC system demonstrated the ability to induce mechanical stress mimicking GI peristalsis and friction.
  • Results indicate compendial methods are insufficient for predicting ER product performance under dynamic GI conditions.

Conclusions:

  • The MAGIC system provides a more physiologically relevant in vitro dissolution testing environment for ER solid oral formulations.
  • This novel apparatus can identify formulation failures not detected by standard compendial dissolution methods.
  • The findings highlight the importance of mechanical forces in the GI tract for drug release and absorption.